Yessotoxin as a tool to study induction of multiple cell death pathways

Toxins

Volumn 4, Issue 7, 2012, Pages 568-579

  Korsnes, Mónica Súarez ^a  

^a NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

Author keywords

Apoptosis; Cancer; Multiple signalling pathways; Neurodegenerative diseases; Paraptosis; Yessotoxin

Indexed keywords

CASPASE 9; DNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; STRESS ACTIVATED PROTEIN KINASE; YESSOTOXIN;

AGAR GEL ELECTROPHORESIS; ALGA; APOPTOSIS; CELL CULTURE; CELL DEATH; CELL LINE; CELL TYPE; CONCENTRATION RESPONSE; DNA FRAGMENTATION; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; ENZYME DEGRADATION; HUMAN; IMMUNOFLUORESCENCE TEST; MYOBLAST; NICK END LABELING; NONHUMAN; NOTE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CELL LINE; HUMANS; MYOBLASTS; OXOCINS; SIGNAL TRANSDUCTION;

ALGAE;

EID: 84864372423     PISSN: 20726651     EISSN: None     Source Type: Journal    
DOI: 10.3390/toxins4070568     Document Type: Note

References (60)

1. Broker, L.; Kruyt, F.; Giaccone, G. Cell death independent of caspases: A review. Clin. Cancer Res. 2005, 11, 3155-3162.
2. Zhivotovsky, B.; Orrenius, S. Cell death mechanisms: Cross-talk and role in disease. Exp. Cell Res. 2010, 316, 1374-1383.
3. Kroemer, G.; Galluzzi, L.; Vandenabeele, P.; Abrams, J.; Alnemri, E.S.; Baehrecke, E.H.; Blagosklonny, M.V.; El-Deiry, W.S.; Golstein, P.; Green, D.R.; et al. Classification of cell death: Recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 2009, 16, 3-11.
4. Galluzzi, L.; Vitale, I.; Abrams, J.M.; Alnemri, E.S.; Baehrecke, E.H.; Blagosklonny, M.V.; Dawson, T.M.; Dawson, V.L.; El-Deiry, W.S.; Fulda, S.; et al. Molecular definitions of cell death subroutines: Recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 2012, 1, 107-120.
5. Bredesen, D.E. Programmed cell death mechanisms in neurological disease. Curr. Mol. Med. 2008, 8, 173-86.
6. Chipuk, J.; Green, D. Do inducers of apoptosis trigger caspase-independent cell death? Nat. Rev. Mol. Cell Biol. 2005, 6, 268-275.
7. K̈ohler, C.; Orrenius, S.; Zhivotovsky, B. Evaluation of caspase activity in apoptotic cells. J. Immunol. Methods 2002, 265, 97-110.
8. Dlamini, Z.; Mbita, Z.; Zungu, M. Genealogy, expression and molecular mechanisms in apoptosis. Pharmacol. Ther. 2004, 10, 1-15.
9. Wang, Z.; Liu, Y.; Liu, Y.; Cui, Y. Pathways to caspase activation. Cell Biol. Int. 2005, 29, 489-496.
10. Gogvadze, V.; Orrenius, S.; Zhivotovsky, B. Multiple pathways of cytochrome c release from mitochondria in apoptosis. Biochim. Biophys. Acta 2006, 1757, 639-647.
11. Kerr, J.F.;Wyllie, A.H.; Currie, A.R. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 1972, 26, 239-257.
12. Hu, W.; Kavanagh, J. Anticancer therapy targeting the apoptotic pathway. Lancet Oncol. 2003, 4, 721-729.
13. Lowe, M.; Lane, J.D.; Woodman, P.G.; Allan, V.J. Caspase-mediated cleavage of syntaxin 5 and giantin accompanies inhibition of secretory traffic during apoptosis. J. Cell. Sci. 2004, 117, 1139-1150.
14. Adams, J.; Cory, S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 2007, 26, 1324-1337.
15. De la Rosa, L.; Alfonso, A.; Vilarino, N.; Vieytes, M.R.; Yasumoto, T.; Botana, L.M. Maitotoxininduced calcium entry in human lymphocytes: Modulation by yessotoxin, Ca2+ channel blockers and kinases. Cell Signal. 2001, 13, 711-716.
16. De la Rosa, L.; Alfonso, A.; Vilarino, N.; Vieytes, M.R.; Yasumoto, T.; Botana, L.M. Modulation of cytosolic calcium levels if human lymphocytes by yessotoxin, a novel marine phycotoxin. Biochem. Pharmacol. 2001, 61, 827-833.
17. Ronzitti, G.; Callegari, F.; Malagati, C.; Rossini, G.P. Selective disruption of the E-cadherin-catenin system by an algal toxin. Br. J. Cancer 2004, 90, 1100-1107.
18. Ṕerez-Ǵomez, A.; Ferrerro-Gutíerrez, A.; Novelli, A.; Franco, J.M.; Paz, B.; Ferńandez-Śanchez, M.T. Potent neurotoxic action of the shellfish biotoxin yessotoxin on cultured cerebellar neurons. Toxicol. Sci. 2006, 90, 168-177.
19. Korsnes, M.S.; Hetland, D.L.; Espenes, A.; Tranulis, M.A.; Aune, T. Apoptotic events induced by yessotoxin in myoblast cell lines from rat and mouse. Toxicol. Vitro 2006, 20, 1077-1087.
20. Korsnes, M.S.; Hetland, D.L.; Espenes, A.; Aune, T. Induction of apoptosis by YTX in myoblast cell lines via mitochondrial signalling transduction pathway. Toxicol. Vitro 2006, 20, 1419-1426.
21. Korsnes, M.S.; Hetland, D.L.; Espenes, A.; Aune, T. Cleavage of tensin during cytoskeleton disruption in YTX-induced apoptosis. Toxicol. Vitro 2007, 21, 9-15.
22. Korsnes, M.S.; Espenes, A. Yessotoxin as an apoptotic inducer. Toxicon 2011, 57, 947-958.
23. Korsnes, M.S.; Espenes, A.; Hetland, D.L.; Hermansen, L.C. Paraptosis-like cell death induced by yessotoxin. Toxicol. Vitro 2011, 25, 1764-1770.
24. Sperandio, S.; de Belle, I.; Bredesen, D. An alternative, nonapoptotic form of programmed cell death. Proc. Natl. Acad. Sci. USA 2000, 97, 14376-14381.
25. Okada, H.; Mak, T.W. Pathways of apoptotic and non-apoptotic death in tumour cells. Nat. Rev. Cancer 2004, 4, 592-603.
26. Brown, J.; Attardi, L. The role of apoptosis in cancer development and treatment response. Nat. Rev. Cancer 2005, 5, 231-237.
27. Ricci, M.; Zong, W. Chemotherapeutic approaches for targeting cell death pathways. Oncologist 2006, 11, 342-357.
28. Eskelinen, E.L. Doctor Jekyll and Mister Hyde: Autophagy can promote both cell survival and cell death. Cell Death Differ. 2005, 12, 1468-1472.
29. Krantic, S.; Mechawar, N.; Reix, S.; Quirion, R. Apoptosis-inducing factor: A matter of neuron life and death. Prog. Neurobiol. 2007, 81, 179-196.
30. Ünal-Çevik, I.; Ki{dotless}li{dotless}nç, M.; Can, A.; Gürsoy-Özdemir, Y.; Dalkara, T. Apoptotic and necrotic death mechanisms are concomitantly activated in the same cell after cerebral ischemia. Stroke 2004, 35, 2189-2194.
31. Boujrad, H.; Gubkina, O.; Robert, N.; Krantic, S.; Susin, S.A. AIF-mediated programmed necrosis: A highly regulated way to die. Cell Cycle 2007, 6, 2612-2619.
32. Kitanaka, C.; Kuchino, Y. Caspase-independent programmed cell death with necrotic morphology. Cell Death Differ. 1999, 6, 508-515.
33. McConkey, D. Biochemical determinants of apoptosis and necrosis. Toxicol. Lett. 1998, 99, 157-168.
34. Nicotera, P.; Leist, M.; Fava, E.; Berliocchi, L.; Volbracht, C. Energy requirement for caspase activation and neuronal cell death. Brain Pathol. 2000, 10, 276-282.
35. Leist, M.; Jaattela, M. Four deaths and a funeral: From caspases to alternative mechanisms. Nat. Rev. Mol. Cell Biol. 2001, 2, 589-598.
36. Yamashima, T. Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Prog. Neurobiol. 2000, 62, 273-295.
37. Foghsgaard, L.; Wissing, D.; Mauch, D.; Lademann, U.; Bastholm, L.; Boes, M.; Elling, F.; Leist, M.; J̈äattel̈a, M. Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J. Cell Biol. 2001, 153, 999-1010.
38. Hoa, N.; Myers, M.; Douglass, T.; Zhang, J.; Delgado, C.; Driggers, L.; Callahan, L.; VanDeusen, G.; Pham, J.; Bhakta, N.; et al. Molecular mechanisms of paraptosis induction: Implications for a non-genetically modified tumor vaccine. PLoS One 2009, 4, doi:10.1371/journal.pone.0004631.
39. Codogno, P.; Meijer, A.J. Autophagy and signaling: Their role in cell survival and cell death. Cell Death Differ. 2005, 12, 1509-1518.
40. Shintani, T.; Klionsky, D.J. Autophagy in health and disease: A double-edged sword. Science 2004, 306, 990-995.
41. Kundu, M.; Thompson, C.B. Macroautophagy versus mitochondrial autophagy: A question of fate? Cell Death Differ. 2005, 12, 1484-1489.
42. Pehar, M.; O'Riordan, K.J.; Burns-Cusato, M.; Andrzejewski, M.E.; del Alcazar, C.G.; Burger, C.; Scrable, H.; Puglielli, L. Altered longevity-assurance activity of p53:p44 in the mouse causes memory loss, neurodegeneration and premature death. Aging Cell 2010, 9, 174-190.
43. Ankarcrona, M.; Dypbukt, J.; Bonfoco, E.; Zhivotovsky, B.; Orrenius, S.; Lipton, S.; Nicotera, P. Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function. Neuron 1995, 15, 961-973.
44. Portera-Cailliau, C.; Price, D.; Martin, L. Non-NMDA and NMDA receptor-mediated excitotoxic neuronal deaths in adult brain are morphologically distinct: Further evidence for an apoptosis-necrosis continuum. J. Comp. Neurol. 1997, 378, 88-104.
45. Leist, M.; Fava, E.; Montecucco, C.; Nicotera, P. Peroxynitrite and nitric oxide donors induce neuronal apoptosis by eliciting autocrine excitotoxicity. Eur. J. Neurosci. 1997, 9, 1488-1498.
46. Melino, G.; Bernassola, F.; Knight, R.; Corasaniti, M.; Nistic, G.; Finazzi-Agr, A. S-nitrosylation regulates apoptosis. Nature 1997, 388, 432-433.
47. Nicotera, P.; Ankarcrona, M.; Bonfoco, E.; Orrenius, S.; Lipton, S.A. Neuronal necrosis and apoptosis: Two distinct events induced by exposure to glutamate or oxidative stress. Adv. Neurol. 1997, 72, 95-101.
48. Ĺopez, L.M.B.; Rancano, A.A.; Vieytes, M.R.; Garcia, M.I.L. Therapeutic Use of Yessotoxins as Human Tumor Cell Growth Inhibitors. EPO Patent EP1875906, 2008.
49. Ĺopez, L.M.B.; Ĺopez, E.A.; Gonzalez, C.V. Use of Yessotoxin and Analogues and Derivatives Thereof for Treating and/or Preserving Neurodegenerative Diseases Linked to Tau and Beta Amyloid. European Patent Application PCT/ES2011/070078, 2011.
50. Nicotera, P.; Leist, M.; Manzo, L. Neuronal cell death: A demise with different shapes. Trends Pharmacol. Sci. 1999, 20, 46-51.
51. Kanasaki, H.; Fukunaga, K.; Takahashi, K.; Miyazaki, K.; Miyamoto, E. Involvement of p38 mitogen-activated protein kinase activation in bromocriptine-induced apoptosis in rat pituitary GH3 cells. Biol. Reprod. 2000, 62, 1486-1494.
52. Palmeri, C.; Petiti, J.; Sosa, L.D.V.; Gutíerrez, S.; Paul, A.D.; Mukdsi, J.; Torres, A. Bromocriptine induces parapoptosis as the main type of cell death responsible for experimental pituitary tumor shrinkage. Toxicol. Appl. Pharmacol. 2009, 240, 55-65.
53. Wang, Y.; Lin, N.; Wang, L.; Ding, P.; Zhang, D.; Han, W.; Ma, D. An alternative form of paraptosis-like cell death, triggered by TAJ/TROY and enhanced by PDCD5 overexpression. J. Cell. Sci. 2004, 117, 1525-1532.
54. Samadder, P.; Bittman, R.; Byun, H.; Arthur, G. A glycosylated antitumor ether lipid kills cells via paraptosis-like cell death. Biochem. Cell. Biol. 2009, 87, 401-414.
55. Li, B.; Zhao, J.; Wang, C.Z.; Searle, J.; He, T.C.; Yuan, C.S.; Du, W. Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53. Cancer Lett. 2011, 301, 185-192.
56. Asare, N.; Landvik, N.; Lagadic-Gossmann, D.; Rissel, M.; Tekpli, X.; Ask, K.; Lag, M.; Holme, J. 1-Nitropyrene (1-NP) induces apoptosis and apparently a non-apoptotic programmed cell death (paraptosis) in Hepa1c1c7 cells. Toxicol. Appl. Pharmacol. 2008, 230, 175-186.
57. Yoon, M.J.; Kim, E.H.; Lim, J.H.; Kwon, T.K.; Choi, K.S. Superoxide anion and proteasomal dysfunction contribute to curcumin-induced paraptosis of malignant breast cancer cells. Free Radic. Biol. Medi. 2010, 48, 713-726.
58. Zhang, J.S.; Li, D.M.; He, N.; Liu, Y.H.; Wang, C.H.; Jiang, S.Q.; Chen, B.Q.; Liu, J.R. A paraptosis-like cell death induced by ̂I-tocotrienol in human colon carcinoma SW620 cells is associated with the suppression of the Wnt signaling pathway. Toxicology 2011, 285, 8-17.
59. Bursch, W.; Hochegger, K.; Torok, L.; Marian, B.; Ellinger, A.; Hermann, R. Autophagic and apoptotic types of programmed cell death exhibit different fates of cytoskeletal filaments. J. Cell. Sci. 2000, 113, 1189-1198.
60. Chi, S.; Kitanaka, C.; Noguchi, K.; Mochizuki, T.; Nagashima, Y.; Shirouzu, M.; Fujita, H.; Yoshida, M.; Chen, W.; Asai, A.; et al. Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells. Oncogene 1999, 18, 2281-2290.